SCHEMBL19080054

SCHEMBL19080054

c1ccc2c(-c3c4ccccc4c(-c4ccc(-c5ccc6c(c5)c5ccccc5c5c6oc6ccc7ccccc7c65)c5ccccc45)c4ccccc34)cccc2c1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 1/20 0.37
ARSA P15289 1/20 0.37
CDC25A P30304 1/20 0.37
CDC25C P30307 1/20 0.37
AHR P35869 3/20 0.35
PAX8 Q06710 2/20 0.35
CYP1A1 P04798 1/20 0.35
CYP1A2 P05177 1/20 0.35
FYN P06241 1/20 0.35
MAPK3 P27361 1/20 0.35
ABCG2 Q9UNQ0 1/20 0.35
NPC1 O15118 2/20 0.35
TDP1 Q9NUW8 2/20 0.35
RAB9A P51151 1/20 0.35
MEN1 O00255 1/20 0.35
TP53 P04637 1/20 0.35
CYP3A4 P08684 1/20 0.35
CYP2D6 P10635 1/20 0.35
MAPT P10636 1/20 0.35
CYP2C9 P11712 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19080024 0.92 ABCG2 (0.40) ARSACDC25ACDC25CAHRPAX8
SCHEMBL19079963 0.92 AHR (0.34) ALOX5ARSACDC25ACDC25CAHR
SCHEMBL19080061 0.91 MCL1 (0.38) ALOX5ARSACDC25ACDC25CCYP1A2
SCHEMBL19080088 0.91 CYP1A1 (0.38) ARSACDC25ACDC25CAHRPAX8
SCHEMBL19080068 0.91 CYP1A1 (0.35) ALOX5ARSACDC25ACDC25CAHR
SCHEMBL19081639 0.91 ALOX5 (0.40) ALOX5ARSACDC25ACDC25CAHR
SCHEMBL17945166 0.89 ALOX5 (0.43) ALOX5ARSACDC25ACDC25CCYP1A2
SCHEMBL17943909 0.89 ALOX5 (0.42) ALOX5ARSACDC25ACDC25CCYP1A2
SCHEMBL19081645 0.88 ALOX5 (0.40) ALOX5ARSACDC25ACDC25CAHR
SCHEMBL19080053 0.87 ALOX5 (0.36) ALOX5ARSACDC25ACDC25CCYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same SAMSUNG DISPLAY CO., LTD. (KR) 2020-03-03 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME SAMSUNG DISPLAY CO., LTD. (KR) 2017-07-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170194571-A1 CONDENSED CYCLIC COMPOUND AND AN ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME CRY1, CRY2, CCNA1 ALOX5 1871/4885ARSA 4452/4885CDC25A 44/4885
US-10580999-B2 Condensed cyclic compound and an organic light-emitting device including the same CRY1, CRY2, CCNA1 ALOX5 1871/4885ARSA 4452/4885CDC25A 44/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.